TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
NKTX

Nkarta Inc

Healthcare · Biotechnology

2.80$ -3.5% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow NKTX
Line item 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – –
– +118.9% +96.0% +123.4% +50.2% +122.6% -61.8% +105.9%
– +418.9% +612.6% +114.3% +16.6% +2.0% -2.7% -48.8%
– -29.3% +37,029.5% -69.9% +16.8% – – –
– – -138.0% – – -67.6% -211.3% –
– +154.4% +289.6% -33.1% +837.5% -40.3% -84.3% -72.6%
– +2,314.0% +1,048.3% – -667.7% – -264.0% –
– +49,729.0% +509.0% -99.4% +24.5% – – –
– +0.0% – – – – – –
– +56,571.1% +565.2% -99.6% +18,120.6% -99.7% +32,618.4% -99.9%
– – +490.1% -144.9% – – – –
– – – – – – – –

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?